Biography and Research Information
OverviewAI-generated summary
Rahul Sharma investigates the complex interplay between the immune system and disease, with a particular focus on regulatory T cells and their role in modulating immune responses. His work has explored how these cells influence conditions such as kidney ischemia-reperfusion injury and autoimmune cholangitis. Sharma has also studied the mechanisms by which oxidized phospholipids trigger inflammation via Toll-like receptor 2, and the impact of immune checkpoint blockade on the immune landscape in obesity-associated breast cancer.
His research also extends to the broader regulation of immunity by cytokines like IL-27 and IL-10, and the potential of novel immunomodulatory cytokines to impact inflammation, diabetes, and obesity, thereby offering protection from diabetic nephropathy. Sharma's publications demonstrate a consistent engagement with animal models, particularly mice, to dissect immune system function and disease pathogenesis. His scholarship metrics include an h-index of 23 and over 1,700 citations, reflecting a significant body of work in the field of immunology and disease mechanisms.
Metrics
- h-index: 23
- Publications: 70
- Citations: 1,724
Positions
-
Associate Professor 2018–presentUniversity of Virginia Center for Immunity Inflammation and Regenerative Medicine, Division of Nephrology, Department of Medicine ORCID
-
Associate ProfessorUniversity of Arkansas for Medical Sciences ORCID
-
Research Assistant Professor 2007–2016University of Virginia Department of Medicine, CIIR/Nephrology ORCID
-
Research Instructor 2006–2007University of Virginia Division of Rheumatology and Immunology, Department of Medicine ORCID
Selected Publications
-
Sudden Death Due to Hypercoagulability in a Patient With Pancreatic Cancer and Diabetic Ketoacidosis (2025)
Collaboration Network
Top Collaborators
- Sudden Death Due to Hypercoagulability in a Patient With Pancreatic Cancer and Diabetic Ketoacidosis
- Sudden Death Due to Hypercoagulability in a Patient With Pancreatic Cancer and Diabetic Ketoacidosis
- Sudden Death Due to Hypercoagulability in a Patient With Pancreatic Cancer and Diabetic Ketoacidosis
Similar Researchers
Based on overlapping research topics